EXPRESSION OF THE CYP1A1 GENE IN PERIPHERAL LYMPHOCYTES AS A MARKER OF EXPOSURE TO CREOSOTE IN RAILROAD WORKERS

被引:0
|
作者
COSMA, GN
TONIOLO, P
CURRIE, D
PASTERNACK, BS
GARTE, SJ
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have conducted a pilot study to assess levels of cytochrome CYP1A1 gene expression in human peripheral lymphocytes as a molecular biomarker assay for polycyclic hydrocarbon exposure. Basal and 3-methylcholanthrene-induced levels of gene expression were measured by standard slot-blot mRNA analyses in mitogen-stimulated cultures of peripheral blood lymphocytes from creosote-exposed railroad workers and unexposed control subjects. Dermal and inhalation exposure of workers to creosote may vary substantially as a function of working conditions related to temperature. Therefore, blood specimens were collected from separate groups during the winter, fall, and summer. Basal and induced CYP1A1 gene expression levels were not elevated in workers from any of the three seasonal studies. However, induced/basal (inducibility) CYP1A1 mRNA ratios from workers sampled in the summer (when actual exposures were greatest) were significantly higher when compared to those of controls (P < 0.01). These studies demonstrate the potential usefulness of specific gene expression assays in human peripheral lymphocytes for the assessment of carcinogen exposure in human populations.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 50 条
  • [31] Upregulation of CYP1A1 and CYP1B1 in HUVEC by shear stress mediates downstream gene expression changes
    Conway, Daniel E.
    Sakurai, Yumiko
    Eskin, Suzanne G.
    McIntire, Larry V.
    FASEB JOURNAL, 2007, 21 (05): : A186 - A186
  • [32] Regulation of cytochrome P450 1A1 (CYP1A1) gene expression by TCDD
    Schmiechen, A
    Buckler, F
    Schmohl, S
    Ittrich, C
    Münzel, P
    Schwarz, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R125 - R125
  • [33] Regulation of NAD(P)H: Quinone oxidoreductase 1 gene expression by CYP1A1 activity
    Marchand, A
    Barouki, R
    Garlatti, M
    MOLECULAR PHARMACOLOGY, 2004, 65 (04) : 1029 - 1037
  • [34] CYP1A1 gene polymorphism and polycystic ovary syndrome
    Esinler, Ibrahim
    Aktas, Dilek
    Otegen, Umit
    Alikasifoglu, Mehmet
    Yarali, Hakan
    Tuncbilek, Ergul
    REPRODUCTIVE BIOMEDICINE ONLINE, 2008, 16 (03) : 356 - 360
  • [35] Role of adrenoceptor-linked signaling pathways in the regulation of CYP1A1 gene expression
    Konstandi, M
    Kostakis, D
    Harkitis, P
    Marselos, M
    Johnson, EO
    Adamidis, K
    Lang, MA
    BIOCHEMICAL PHARMACOLOGY, 2005, 69 (02) : 277 - 287
  • [36] CYP1A1 gene variant, vascular disease and diabetes
    Wang, J
    Greco, M
    Sim, AS
    Duarte, N
    Wilcken, DEL
    Wang, XL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 680 - 680
  • [37] Phenobarbital induction of CYP1A1 gene expression in a primary culture of rainbow trout hepatocytes
    Sadar, MD
    Ash, R
    Sundqvist, J
    Olsson, PE
    Andersson, TB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) : 17635 - 17643
  • [38] Potent Modification of Inducible CYP1A1 Expression by Flavonoids
    Chatuphonprasert, Waranya
    Kondo, Sachiko
    Jarukamjorn, Kanokwan
    Kawasaki, Yuki
    Sakuma, Tsutomu
    Nemoto, Nobuo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2010, 33 (10) : 1698 - 1703
  • [39] Down-regulation of CYP1A1 expression by eugenol
    Han, EH
    Kim, JY
    Jeong, HG
    DRUG METABOLISM REVIEWS, 2004, 36 : 146 - 146
  • [40] Regulation of CYP1A1 gene expression by oxidative stress: Mechanisms and biological implications.
    Barouki, R
    Garlatti, M
    Marchand, A
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S59 - S59